Back
Marker Therapeutics Vs. Armata Pharmaceuticals Industry Stock Comparison
Buy
53
MRKR
Marker Therapeutics
Last Price:
$3.79
Seasonality Move:
35.24%
Sell
43
ARMP
Armata Pharmaceuticals
Last Price:
$1.90
Seasonality Move:
10.32%
Buy
53
Marker Therapeutics (MRKR)
is a Buy
Is Marker Therapeutics a Buy, Sell or Hold?
-
The current Marker Therapeutics [MRKR] share price is $3.80. The Score for MRKR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
MRKR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Armata Pharmaceuticals (ARMP)
is a Sell
Is Armata Pharmaceuticals a Buy, Sell or Hold?
-
The current Armata Pharmaceuticals [ARMP] share price is $1.95. The Score for ARMP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ARMP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRKR Stock Price Chart
What is Marker Therapeutics's stock price today?
-
The Marker Therapeutics share price today is $3.80The current trend is moderately bearish and MRKR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARMP Stock Price Chart
What is Armata Pharmaceuticals's stock price today?
-
The Armata Pharmaceuticals share price today is $1.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARMP is experiencing slight buying pressure.
MRKR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 50.16 | Buy |
Chaikin Money Flow: | 26341 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.11 - 4.11) | Buy |
Bollinger Bands (100): | (2.89 - 4.01) | Buy |
ARMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 37.05 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.03 - 2.29) | Sell |
Bollinger Bands (100): | (2.16 - 2.5) | Sell |
MRKR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.16 | Sell |
20-day SMA: | 3.75 | Buy |
50-day SMA: | 3.71 | Buy |
200-day SMA: | 3.97 | Sell |
8-day EMA: | 4 | Sell |
20-day EMA: | 3.85 | Sell |
50-day EMA: | 3.68 | Buy |
200-day EMA: | 3.81 | Sell |
ARMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.05 | Sell |
20-day SMA: | 2.16 | Sell |
50-day SMA: | 2.27 | Sell |
200-day SMA: | 2.66 | Sell |
8-day EMA: | 2.03 | Sell |
20-day EMA: | 2.13 | Sell |
50-day EMA: | 2.23 | Sell |
200-day EMA: | 2.52 | Sell |
Marker Therapeutics Earnings Growth & MRKR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $1.14 per share.
Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and a decrease next year of $0.75 per share.
Marker Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Armata Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |